Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Clinical trial NCT07220759 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07220759
- Sponsor
- Novo Nordisk A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-05
- Primary completion
- 2027-05-12
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.